PHEN Header
PHEN eNewsletter | December, 2012
Webcast : Wednesday, December 12
"Precision Therapy for Advanced Prostate Cancer"
 
PHEN's December meeting and webcast will feature a presentation by Dr. Philip Kantoff about the Stand Up to Cancer (SU2C) Dream Team project titled "Precision Therapy for Advanced Prostate Cancer."  Dr. Kantoff will provide a detailed description of the project and outline opportunities, benefits and requirements for patients to participate.

This project could help identify and better understand any prostate cancer genetic aberrations that might be more common to African American patients and which therapies might work best. PHEN is working with the Dream Team to provide education about the project and to assist in enrolling patients.

Philip W. Kantoff, MD, Dana Farber Cancer Institute; 
Chief, Division of Solid Tumor Oncology; Chief Clinical Research Officer; Director, Lank Center for Genitourinary Oncology; Professor of Medicine, Harvard Medical School

*Webcast link live at 6 pm ET, Wed. Dec.12 : PHEN Webcast*
Treatments and Clinical Trials Headlines 


 



                      Treatment           



In This Issue
President's Corner
Farrington Profile
PHEN Thanks its National Sponsors and Partners
Abbott
Accuray
Amgen
Astellas / Medivation
Bayer
BN ImmunoTherapeutics
Dana-Farber
Dendreon
Genentech
Janssen Biotech
Millenium / Takeda
 
Join the Fight Against Prostate Cancer! 
During this Holiday Season please make a donation supporting PHEN's efforts to increase knowledge to defend against prostate cancer and save lives...

PHEN Has Moved! 
We are now located at:  
500 Victory Rd.  
Fourth Floor 
Quincy, MA 02171 
 
Our New Telephone and Fax:
Telephone: 617-481-4020 
Fax: 617-481-4021
Blue Ribbon
Stay Connected

Like us on Facebook   Follow us on Twitter  View our videos on YouTube
PHEN | 617-481-4020 | rapcancer@prostatehealthed.org | http://www.prostatehealthed.org
500 Victory Rd.
Fourth Floor
Quincy, MA 02171
www.rapcancer.org